1.Postoperative pain & plasma endorphin level.
Hang Chul LEE ; Young Gwan KO ; Hoong Zae JOO
Journal of the Korean Surgical Society 1993;45(4):479-485
No abstract available.
Endorphins*
;
Pain, Postoperative*
;
Plasma*
2.A clinical study of blunt abdominal trauma sustained from motor-vehicle accident.
Hee Soo LEE ; Young Gwan KO ; Hoong Zae JOO
Journal of the Korean Society of Emergency Medicine 1991;2(1):80-90
No abstract available.
3.Efficacy of Pain Mapping in Patients with Endometriosis Using Microlaparoscopy.
Gyung Ho LEE ; Young Gun JANG ; Gwan Young JOO ; In Gook LEE
Korean Journal of Obstetrics and Gynecology 2000;43(12):2166-2169
No abstract available.
Endometriosis*
;
Female
;
Humans
4.Prediction of Cancer Incidence and Mortality in Korea, 2022
Kyu-Won JUNG ; Young-Joo WON ; Mee Joo KANG ; Hyun-Joo KONG ; Jeong-Soo IM ; Hong Gwan SEO
Cancer Research and Treatment 2022;54(2):345-351
Purpose:
This study aimed to report the projected cancer incidence and mortality for the year 2022 to estimate Korea’s current cancer burden.
Materials and Methods:
Cancer incidence data from 1999 to 2019 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2020 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against their respective years and then by multiplying the projected age-specific rates by the anticipated age-specific population for 2022. A joinpoint regression model was used to determine the year in which the linear trend changed significantly; we only used the data of the latest trend.
Results:
In total, 274,488 new cancer cases and 81,277 cancer deaths are expected to occur in Korea in 2022. The most common cancer site is expected to be the thyroid, followed by the lung, colon and rectum, breast, and stomach. These five cancers are expected to represent half of the overall burden of cancer in Korea. The most common type of cancer leading to death is expected to be lung cancer, followed by liver, colorectal, pancreatic, and gallbladder cancers.
Conclusion
The incidence rates for all types of cancer in Korea are estimated to gradually decrease. These up-to-date estimates of the cancer burden in Korea could be an important resource for planning and evaluating cancer-control programs.
5.A Survey on Ostomates With the special reference to physical, psychosocial and sexual problems.
Hyun Seog SO ; Seok Hwan LEE ; Young Gwan KO ; Soo Myung OH ; Choong YOON ; Hoong Zae JOO ; Kee Hyung LEE
Journal of the Korean Society of Coloproctology 1998;14(3):447-454
The survey was undertaken among the 105 ostomates who attended the 2nd Workshop for Stoma Rehabilitation on Aug. 30th, 1997 by the Department of Surgery, Kyung-Hee University Hospital to assess the physical, psychosocial and sexual problems with a stoma. The 97% of ostomates had permanent colostomies following abdominoperineal resection. The 67% of ostomates had one or more physical problems caused by stoma. Frequent bowel movement (94.3%), impairment of irrigation (64.6%), unpleasant odor (27.3%), and urinary frequency (21.3%) were common problems encountered by ostomates. Concerning the psychosocial problems, 3.8% of them suffered from profound restriction of social activities and 1.9% of them had psychologic problems such as depression. 42 of 58 ostomates (72.4%) who were employed before operation returned to their work. Among 71 men, 44 (62%) were impaired by sexual function. Most ostomates suffered physical, social, psychologic and sexual problems in their daily life and needed helps of experts such colorectal surgeons, enterostomal therapists, and ostomy association. Attention is needed more to improve the quality of life for the ostomates.
Colostomy
;
Depression
;
Education
;
Humans
;
Male
;
Odors
;
Ostomy
;
Quality of Life
;
Rehabilitation
6.Reciprocal ST-segment depression in acute inferior myocardial infarction : Possible indicator of concomitant left anterior descending coronary artery stenosis.
Jeong Gwan CHO ; Young Keun AHN ; Joo Hyung PARK ; Myung Ho JEONG ; Jong Chun PARK ; Jung Chaee KANG
Korean Circulation Journal 1993;23(3):350-355
BACKGROUND: Reciprocal ST-segment depression in precordial leads is a common finding in acute inferior myocardial infarction. The responsible mechanism and the significance of this finding, however, are still controversial. METHODS: Clinical characteristics, serial eletrocardiograms, angiographic findings of coronary artery and left ventricle were reviewed in 33 patients with acute inferior myocardial infarction. Reciprocal ST-segment depression was defined as ST-segment depression > or =1.0mm in two or more adjacent chest leads, I and aVL in patients with acute inferior myocardial infarction showing ST-segment elevation in II, III, aVF. Coronary angiography and left ventriculography were performed 15,2+/-16.9 hours after arrival. RESULTS: Eleven patients did not have reciprocal ST-segment depression(group A) and 22 patients had reciprocal ST-segment depression(group B). There was no significant difference in the demographic data of the patients except age and peak CK-MB, which were significantly higher in group B than group A. Left anterior descending coronary artery(LAD) stenosis was significantly more frequent in group B than group A(54.5% vs 18.2%, p<0.05). However the distribution of left ventricular regional wall motion abnormality and global ejection fraction showed no difference between two groups. In addition, there was no difference in in-hospital complications. CONCLUSIONS: These results suggest that reciprocal ST-segment depression in acute inferior myocardial infarction can be explained by anterior ischemia due to concomitant LAD stenosis in some cases, but its clinical significance is limited at least in terms of in-hospital complications.
Constriction, Pathologic
;
Coronary Angiography
;
Coronary Stenosis*
;
Coronary Vessels*
;
Depression*
;
Heart Ventricles
;
Humans
;
Inferior Wall Myocardial Infarction*
;
Ischemia
;
Thorax
7.Clinical Efficacy of Trimetazidine(Vastinan(R)) in the Treatment of Stable Angina.
Jung Chaee KANG ; Young Keun AHN ; Joo Hyung PARK ; Myung Ho JEONG ; Jeong Gwan CHO ; Jong Chun PARK
Korean Circulation Journal 1993;23(5):735-740
BACKGROUND: Trimetazidine(Vastinan(R)) is a new antianginal agent of different action mechanism specifically targeted at the metabolic cellular consequences of myocardial ischemia. The clinical efficacy of the Trimetazidine in angina pectoris is still to be defined. METHOD: To determine the antianginal effect of trimetazidine in the treatment of ischemic heart disease, 15 patients with stable angina(12 male, 3 female, mean age : 59.3 years) were studied. In 6 cases as a single agent and in 9 cases as an additive regimen to conventional antianginal medications. Trimetazidine(20mg 3 times daily) was given for 30 days or more to evaluate the clinical effect. Graded exercise tests were carried out before the trial of Trimetazidine and on the 30th day of the treatment period. RESULTS: 1) The number of episodes of anginal attacks decreased from 4.2+/-2.7 to 2.0+/-0.5 a week(p<0.05) after treatment with Trimetazidine. 2) Trimetazidine also significantly increased the duration of total exercise from 12.1+/-4.7 min to 14.5+/-3.3 min(p<0.05), and the time to 1mm ST segment depression from 7.7+/-5.9 min to 11.7+/-5.2 min(p<0.05) on treadmill exercise by modified Bruce protocol. 3) Total workload (METs) and rate pressure double product(heart rate x systolic blood pressure) slightly increased, but the differences were not significant statistically. 4) No serious clinical side effects were observed during the treatment. CONCLUSION: These results suggest that the Trimetazidine is an effective and safe as an antianginal drug in the treatment of stable angina patients as a single agent and as an additive regimen when the patients are refractory to conventional drugs.
Angina Pectoris
;
Angina, Stable*
;
Depression
;
Exercise Test
;
Female
;
Humans
;
Male
;
Myocardial Ischemia
;
Trimetazidine
8.A Case of D-Penicillamine Induced Iga Nephropathy in a Patients with Scleroderma.
Jung Yong LEE ; Eung Joo KIM ; Young Ho LEE ; Jong Dae JI ; Nam Hee WON ; Gwan Gyu SONG
The Journal of the Korean Rheumatism Association 1997;4(1):100-104
IgA nephropathy can occur rarely as a complication of D-penicillamine treatment, but it is exact pathogenesis remains unclear. If a patients has gross or microscopic hematuria during D-penicillamine treatment, D-penicillamine induced IgA nephropathy should be suspected as a cause of hematuria. In those cases, renal biopsy should be taken for diagnosis and proper management. We experienced a case of IgA nephropathy confirmed by renal biopsy in a 39-years-old female patient with scleroderma during D-penicillamine therapy and report this case with a review of literature.
Biopsy
;
Diagnosis
;
Female
;
Glomerulonephritis, IGA*
;
Hematuria
;
Humans
;
Immunoglobulin A*
;
Penicillamine*
9.Coronary angiographic morphology of unstable angina.
Joo Hyung PARK ; Young Keun AHN ; Myung Ho JEONG ; Jung Gwan CHO ; Jong Chun PARK ; Jung Chaee KANG
Korean Journal of Medicine 1993;45(4):446-455
No abstract available.
Angina, Unstable*
10.Prediction of Cancer Incidence and Mortality in Korea, 2021
Kyu-Won JUNG ; Young-Joo WON ; Seri HONG ; Hyun-Joo KONG ; Jeong-Soo IM ; Hong Gwan SEO
Cancer Research and Treatment 2021;53(2):316-322
Purpose:
This study aimed to report the projected cancer incidence and mortality for the year 2021 to estimate Korea’s current cancer burden.
Materials and Methods:
Cancer incidence data from 1999 to 2018 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2019 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against their respective years and then by multiplying the projected age-specific rates by the anticipated age-specific population for 2021. A joinpoint regression model was used to determine the year in which the linear trend changed significantly; we only used the data of the latest trend.
Results:
In total, 259,999 new cancer cases and 81,567 cancer deaths are expected to occur in Korea in 2021. The most common cancer site is expected to be the lung, followed by the thyroid, colon and rectum, breast, and stomach. These five cancers are expected to represent half of the overall burden of cancer in Korea. The most common type of cancer leading to death is expected to be lung cancer, followed by liver, colorectal, pancreatic, and stomach cancers.
Conclusion
The incidence rates for all types of cancer in Korea are estimated to gradually decrease. These up-to-date estimates of the cancer burden in Korea could be an important resource for planning and evaluating cancer-control programs.